No abstract available.
Humans ; Living Donors*

No abstract available.
Humans ; Living Donors*

No abstract available.
Humans ; Kidney Transplantation* ; Living Donors*

No abstract available.
Humans ; Kidney Transplantation* ; Living Donors*

The field of renal transplantation has undergone continual evolution to become the standard treatment for patients with end-stage renal diseases. The attempts to improve organ shortage, studies for clinical and basic science, empirical trial of new immunosuppressive drugs and technical challenges are very important for the development of renal transplantation medicine and improved patient outcome. This review will focus on the recent advancement and current hot issues of living donor renal transplantation worldwide.
Humans ; Kidney Transplantation* ; Living Donors*

No abstract available.
Humans ; Kidney* ; Living Donors* ; Transplants*

Living donor liver transplantation - achievement in some great Asian centres as follows: There were 306 cases of liver transplantation for 292 patients at Queen Mary Hospital, Hong Kong Medical College, from October 1991 to September 2003; There were 148 cases of living donor liver transplantation at Chang Gung Memorial Hospital, Kaohsiung, Taipei from June 1994 to October 2003; There were 227 cases of living donor liver transplantation at Tokyo Medical Centre, Japan, from Jan. 1996 to June 2003; In 2002 there were 127 cases of living donor liver transplantation at Asan Medical Centre, Seoul, Korea. Living donor liver transplantation technique was made at some Asian Hospitals, mostly at Asan Medical Centre of Korea. It is different from european countries, most of liver transplantation in Asian were taken from the living donors
Liver Transplantation ; Living Donors ; epidemiology

Living related liver transplantation (LRLT) has been developed as a rescue for the ever deteriorating shortage of cadaveric donor liver, especially in Asian countries and areas where the concept of brain death has not widely been accepted. Inclusion criteria for the biologically suitable potential donor of LRLT should be strict and approved by the ethical committee of the hospital before clinical evaluation is taken. Anatomical, physiological and clinical practices have proved that donor mortality is acceptably very low. The early and middle-long term results for the recipient of LRLT is comparable with and even better than those of cadaveric liver transplantation. In mainland China, interest in LRLT is surging with the volume ever increased and donor's safety guaranteed.
Humans ; Liver Transplantation ; Living Donors

No abstract available.
Allografts* ; Humans ; Living Donors* ; Prospective Studies*

No abstract available.
Humans ; Liver Transplantation* ; Liver* ; Living Donors*